0001415889-22-007024.txt : 20220628
0001415889-22-007024.hdr.sgml : 20220628
20220628163719
ACCESSION NUMBER: 0001415889-22-007024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220627
FILED AS OF DATE: 20220628
DATE AS OF CHANGE: 20220628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CAUSEY CHRISTOPHER
CENTRAL INDEX KEY: 0001237334
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 221050639
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-06282022_010609.xml
X0306
4
2022-06-27
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001237334
CAUSEY CHRISTOPHER
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
Common Stock
2022-06-27
4
M
0
5000
76.36
A
5675
D
Common Stock
2022-06-27
4
S
0
5000
236.79
D
675
D
Stock Options
76.36
2022-06-27
4
M
0
5000
0
D
2020-06-26
2029-06-26
Common Stock
5000
0
D
This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
/s/ John S. Hess Jr. under Power of Attorney
2022-06-28